{"id":"W3003334583","doi":"10.1111/bjd.18898","title":"Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":379,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Lundbeckfonden; Eli Lilly and Company","keywords":"Medicine; Placebo; Atopic dermatitis; Concomitant; Adverse effect; Randomized controlled trial; Internal medicine; Gastroenterology; Clinical endpoint; Erythema; Phases of clinical research; Clinical trial; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00472845,0.001064096,0.00354123,0.000290542,0.0004036727,0.001281677,0.0007464393,0.001618648,0.002483871],"category_scores_gemma":[0.003472251,0.000497936,0.003199676,0.0005497424,0.0007300928,0.0007892118,0.0003258314,0.001806329,0.0003827725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001047935,"about_ca_system_score_gemma":0.001305365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00113374,"about_ca_topic_score_gemma":0.003878999,"domain_scores_codex":[0.998522,0.0008117813,0.0001769494,0.0001877571,0.0001472433,0.0001542711],"domain_scores_gemma":[0.9975836,0.000823384,0.0007578701,0.0001944909,0.0002492248,0.0003913762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9367341,0.00378845,0.002957106,0.002712592,0.007244057,0.00007076086,0.00008816399,0.0002815018,0.004790672,0.00009160682,0.00165501,0.03958603],"study_design_scores_gemma":[0.9446081,0.04053284,0.008365287,0.0001718233,0.004300288,0.0001213981,0.00003345649,0.0002053822,0.0004274127,0.00008607588,0.001126478,0.00002139194],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9418753,0.04826272,0.0006894452,0.001637675,0.0005861167,0.00297768,0.001200267,0.00008415726,0.002686589],"genre_scores_gemma":[0.9812034,0.01217104,0.0009144184,0.001395102,0.000460483,0.001654918,0.001306958,0.00001738586,0.0008763055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00472845,"threshold_uncertainty_score":0.02500671,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01951308054702021,"score_gpt":0.2875085191582279,"score_spread":0.2679954386112077,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}